We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Luxcel Biosciences announced they have entered a strategic partnership to co‐market and provide new assay technologies for preclinical drug safety services.
Research results published in the BMJ suggest that post-marketing studies funded by drug companies may be too small to detect rare side effects, as reported in Yahoo!Finance.